Myocardial Pro-inflammatory Cytokine Expression and Cellular Rejection in Pediatric Heart Transplant Recipients

Journal of Heart and Lung Transplantation

Volumn 27, Issue 3, 2008, Pages 317-324

  Breinholt, John P ^a   Vallejo, Jesus G ^a   Gates, Corey M ^a   Clunie, Sarah K ^a   Kearney, Debra L ^a   Dreyer, William J ^a   Towbin, Jeffrey A ^a   Bowles, Neil E ^a  

^a TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; DNA; GAMMA INTERFERON; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; MESSENGER RNA; RNA; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; ARTICLE; CARDIAC GRAFT REJECTION; CATHETERIZATION; CELLULAR REJECTION; CORRELATION ANALYSIS; DISEASE COURSE; DNA SYNTHESIS; FEMALE; GENETIC TRANSCRIPTION; GRAFT RECIPIENT; GRAFT REJECTION; HEART GRAFT; HEART MUSCLE BIOPSY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PARVOVIRUS; PEDIATRICS; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION; RNA EXTRACTION; SCHOOL CHILD; TIME SERIES ANALYSIS; VIRUS GENOME;

ADOLESCENT; ADULT; BIOPSY; CHILD; CHILD, PRESCHOOL; CYTOKINES; DISEASE PROGRESSION; DNA, VIRAL; GRAFT REJECTION; HEART; HEART TRANSPLANTATION; HUMANS; INFANT; INTERFERON TYPE II; INTERLEUKIN-18; INTERLEUKIN-1BETA; INTERLEUKIN-6; MYOCARDIUM; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PROSPECTIVE STUDIES; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA;

EID: 40749091732     PISSN: 10532498     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.healun.2007.12.002     Document Type: Article

References (29)

1. Birks E.J., Burton P.B., Owen V., et al. Elevated tumor necrosis factor-alpha and interleukin-6 in myocardium and serum of malfunctioning donor hearts. Circulation 102 suppl 3 (2000) III-352-III-358
2. Guillonneau C., Louvet C., Renaudin K., et al. The role of TNF-related activation-induced cytokine-receptor activating NF-kappa B interaction in acute allograft rejection and CD40L-independent chronic allograft rejection. J Immunol 172 (2004) 1619-1629
3. Kuo E., Maruyama T., Fernandez F., and Mohanakumar T. Molecular mechanisms of chronic rejection following transplantation. Immunol Res 32 (2005) 179-186
4. Baan C.C., van Emmerik N.E., Balk A.H., et al. Cytokine mRNA expression in endomyocardial biopsies during acute rejection from human heart transplants. Clin Exp Immunol 97 (1994) 293-298
5. de Groot-Kruseman H.A., Mol W.M., Niesters H.G., et al. Differential intragraft cytokine messenger RNA profiles during rejection and repair of clinical heart transplants. A longitudinal study. Transplant Int 16 (2003) 9-14
6. Larsen C.P., Elwood E.T., Alexander D.Z., et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 381 (1996) 434-438
7. Morgan C., Pelletier R., Hernandez C., et al. Cytokine mRNA expression during development of acute rejection in murine cardiac allografts. Transplant Proc 25 (1993) 114-116
8. Mottram P.L., Han W.R., Purcell L.J., McKenzie I.F., and Hancock W.W. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 59 (1995) 559-565
9. Wu C.J., Lovett M., Wong-Lee J., et al. Cytokine gene expression in rejecting cardiac allografts. Transplantation 54 (1992) 326-332
10. Takeuchi T., Lowry R.P., and Konieczny B. Heart allografts in murine systems. The differential activation of Th2-like effector cells in peripheral tolerance. Transplantation 53 (1992) 1281-1294
11. Xia D., Sanders A., Shah M., Bickerstaff A., and Orosz C. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice. Transplantation 72 (2001) 907-914
12. Olsen E.G. Endomyocardial biopsies. Int J Cardiol 3 (1983) 240-243
13. Gwechenberger M., Mendoza L.H., Youker K.A., et al. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions. Circulation 99 (1999) 546-551
14. Raymond R.J., Dehmer G.J., Theoharides T.C., and Deliargyris E.N. Elevated interleukin-6 levels in patients with asymptomatic left ventricular systolic dysfunction. Am Heart J 141 (2001) 435-438
15. Plenz G., Song Z.F., Reichenberg S., et al. Left-ventricular expression of interleukin-6 messenger-RNA higher in idiopathic dilated than in ischemic cardiomyopathy. Thorac Cardiovasc Surg 46 (1998) 213-216
16. Kanda T., McManus J.E., Nagai R., et al. Modification of viral myocarditis in mice by interleukin-6. Circ Res 78 (1996) 848-856
17. Plenz G., Eschert H., Erren M., et al. The interleukin-6/interleukin-6-receptor system is activated in donor hearts. J Am Coll Cardiol 39 (2002) 1508-1512
18. Shirali G.S., Ni J., Chinnock R.E., Johnston J.K., et al. Association of viral genome with graft loss in children after cardiac transplantation. N Engl J Med 344 (2001) 1498-1503
19. Schowengerdt K.O., Ni J., Denfield S.W., et al. Diagnosis, surveillance, and epidemiologic evaluation of viral infections in pediatric cardiac transplant recipients with the use of the polymerase chain reaction. J Heart Lung Transplant 15 (1996) 111-123
20. Schowengerdt K.O., Ni J., Denfield S.W., et al. Association of parvovirus B19 genome in children with myocarditis and cardiac allograft rejection: diagnosis using the polymerase chain reaction. Circulation 96 (1997) 3549-3554
21. Pauschinger M., Bowles N.E., Fuentes-Garcia F.J., et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99 (1999) 1348-1354
22. Francalanci P., Chance J.L., Vatta M., et al. Cardiotropic viruses in the myocardium of children with end-stage heart disease. J Heart Lung Transplant 23 (2004) 1046-1052
23. Billingham M.E., Cary N.R., Hammond, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection. J Heart Transplant 9 (1990) 587-593
24. Dijke I.E., Velthuis J.H., Balk A.H., et al. Donor-specific cytotoxic hyporesponsiveness associated with high interleukin-10 messenger RNA expression in cardiac allograft patients. J Heart Lung Transplant 25 (2006) 955-964
25. Lenzo J.C., Mansfield J.P., Sivamoorthy S., Cull V.S., and James C.M. Cytokine expression in murine cytomegalovirus-induced myocarditis: modulation with interferon-alpha therapy. Cell Immunol 223 (2003) 77-86
26. Poulin L.F., Richard M., Le Moine A., et al. Interleukin-9 promotes eosinophilic rejection of mouse heart allografts. Transplantation 76 (2003) 572-577
27. Wang H., Hosiawa K.A., Min W., et al. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. J Immunol 171 (2003) 3823-3836
28. Bultmann B.D., Klingel K., Sotlar K., et al. Fatal parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: an endothelial cell-mediated disease. Hum Pathol 34 (2003) 92-95
29. Kerr J.R., Cunniffe V.S., Kelleher P., Coats A.J., and Mattey D.L. Circulating cytokines and chemokines in acute symptomatic parvovirus B19 infection: negative association between levels of pro-inflammatory cytokines and development of B19-associated arthritis. J Med Virol 74 (2004) 147-155